Spyre Therapeutics Statistics
NASDAQ: SYREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
85.92+6.02 (+7.53%)
Market open · Delayed 15 min · as of Oct 9, 1:09 PM ET
Spyre Therapeutics by the numbers
Spyre Therapeutics has a market capitalization of $7.93 billion based on 92.29M shares outstanding. With trailing EPS of $-1.92, Spyre Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.2% below its 50-day average and 25.2% above its 200-day average.
Average daily trading volume is 1.22M shares, or about $104.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SYRE valuation vs. peer median
| Metric | SYRE | Peer median | Difference |
|---|---|---|---|
| Market cap | $7.93B | $7.14B | +11% |
| Avg. volume | 1.22M | 1.49M | -18% |
Peer median across 8 companies: PRAX, IONS, ABVX, AMRX, ALKS, RYTM, TGTX, KNSA.
Valuation
- Market cap
- $7.93B
- EPS (TTM)
- $-1.92
- Shares outstanding
- 92.29M
Price and trading
- Previous close
- 79.90
- Open
- 79.90
- Day range
- 78.73 – 85.92
- 52-week range
- 18.12 – 110.18
- 52-week change
- +351.92%
- Beta
- —
- Volume
- 462.38K
- Average volume
- 1.22M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 7.93B
- Forward Pe
- -24.41
- Eps
- -1.92
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 110.18
- Week52 Low
- 18.12
- Avg Volume
- 1.22M
- Shares Outstanding
- 92.29M
- Ma50
- 94.65
- Ma200
- 68.63
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -22.01%
- Pct From52w Low
- 374.17%